Former FDAers: Retaining Califf At FDA Would Maintain Continuity, Bipartisan Efforts

November 11, 2016 at 7:42 PM
If President-elect Donald Trump elects to retain current-FDA Commissioner Robert Califf in his administration it would help maintain continuity at the agency as well as the bipartisan direction Califf has plotted for key policy goals such as precision medicine, accelerating cures for cancer, big data and real-world evidence, two former FDA leaders told Inside Health Policy . Califf has been rumored as a potential political appointee who may keep his post, according to former Commissioner Mark McClellan, who led the...


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.